Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Wei, Chen Chao ^a   You, Fan Tian ^a   Mei, Li Yu ^a   Jian, Sun ^a   Qiang, Chen Yong ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Juxta articular; Osteoporosis; Receptor activator of nuclear factor B ligand; Rheumatoid arthritis; Total glucosides of paeony

Indexed keywords

GLUCOSIDE; INDOMETACIN; MESSENGER RNA; OSTEOPROTEGERIN; PAEONIA RADIX; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE DENSITY; BONE RADIOGRAPHY; CARTILAGE CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; JOINT CAVITY; KNEE; MITOCHONDRION; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; ROUGH ENDOPLASMIC RETICULUM; SUBCHONDRAL BONE PLATE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION; CHONDROCYTES; GLUCOSIDES; KNEE JOINT; OSTEOPOROSIS; OSTEOPROTEGERIN; PAEONIA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RABBITS; RANK LIGAND; RNA, MESSENGER;

EID: 84881246188     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-186     Document Type: Article

References (42)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010, 376:1094-1108. 10.1016/S0140-6736(10)60826-4, 20870100.
2. Karsdal MA, Woodworth T, Henriksen K, Maksymowych WP, Genant H, Vergnaud P, Christiansen C, Schubert T, Qvist P, Schett G, Platt A, Bay-Jensen AC. Biochemical markers of ongoing joint damage in rheumatoid arthritis-current and future applications, limitations and opportunities. Arthritis Res Ther 2011, 13:215. 10.1186/ar3280, 3132026, 21539724.
3. Marotte H, Miossec P. Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy. Biologics 2008, 2:663-669. 2727908, 19707447.
4. Gluszko P. Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis. Endokrynol Pol 2009, 60:115-121.
5. Nakashima T, Hayashi M, Takayanagi H. Bone and calcium update; bone research update. Osteoclastogenesis and osteoimmunology. Clin Calcium 2011, 21:93-102.
6. Mori H, Kitazawa R, Mizuki S, Nose M, Maeda S, Kitazawa S. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. Histochem Cell Biol 2002, 117:283-292. 10.1007/s00418-001-0376-9, 11914926.
7. Ho TY, Santora K, Chen JC, Frankshun AL, Bagnell CA. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Bone 2011, 48:1346-1353. 10.1016/j.bone.2011.03.684, 21419242.
8. Martíez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res Ther 2012, 14:R149. 10.1186/ar3884, 3446534, 22709525.
9. Franke S, Rüster C, Pester J, Hofmann G, Oelzner P, Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol 2011, 29:650-660.
10. Pulsatelli L, Dolzani P, Silvestri T, Boiardi L, Salvarani C, Macchioni P, Facchini A, Meliconi R. Circulating RANKL/OPG in polymyalgia rheumatica. Clin Exp Rheumatol 2007, 25:621-623.
11. Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, Takayanagi H, Kamijo R. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med 2009, 15:1066-1071. 10.1038/nm.2007, 2755267, 19718038.
12. Sugimoto T. Anti-RANKL monoclonal antibody Denosumab (AMG162). Clin Calcium 2011, 21:46-51.
13. Oelzner P, Franke S, Lehmann G, Eidner T, Hein G, Wolf G. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. Rheumatol Int 2012, 32:199-206. 10.1007/s00296-010-1606-z, 20821212.
14. Arabi A, Baddoura R, Awada H, Khoury N, Haddad S, Ayoub G, El-Hajj Fuleihan G. Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures. Bone 2007, 40:1060-1065. 10.1016/j.bone.2006.11.017, 17223616.
15. Finckh A, Bansback N, Marra CA, Anis AH, Michaud K, Lubin S, White M, Sizto S, Liang MH. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med 2009, 151:612-621. 10.7326/0003-4819-151-9-200911030-00006, 19884622.
16. Suresh E. Recent advances in rheumatoid arthritis. Postgrad Med J 2010, 86:243-250. 10.1136/pgmj.2009.090399, 20354048.
17. Itoh K, Kitakoji H. Acupuncture for chronic pain in Japan: a review. Evid Based Complement Alternat Med 2007, 4:431-438. 10.1093/ecam/nel092, 2176146, 18227910.
18. Ernst E. Herbal medicine in the treatment of rheumatic diseases. Rheum Dis Clin North Am 2011, 37:95-102. 10.1016/j.rdc.2010.11.004, 21220089.
19. Zhang W, Dai SM. Mechanisms involved in the therapeutic effects of Paeonia lactiflora Pallas in rheumatoid arthritis. Int Immunopharmacol 2012, 14:27-31. 10.1016/j.intimp.2012.06.001, 22705050.
20. Zhao M, Liang GP, Tang MN, Luo SY, Zhang J, Cheng WJ, Chan TM, Lu QJ. Total glucosides of paeony induces regulatory CD4(+)CD25(+) T cells by increasing Foxp3 demethylation in lupus CD4(+) T cells. Clin Immunol 2012, 143:180-187. 10.1016/j.clim.2012.02.002, 22406048.
21. Chang Y, Wei W, Zhang L, Xu HM. Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis. J Ethnopharmacol 2009, 121:43-48. 10.1016/j.jep.2008.09.028, 18977427.
22. Xu HM, Wei W, Jia XY, Chang Y, Zhang L. Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats. J Ethnopharmacol 2007, 109:442-448. 10.1016/j.jep.2006.08.019, 17000070.
23. He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall, a traditional chinese herbal medicine. Front Pharmacol 2011, 2:10. 3108611, 21687505.
24. Largo R, Sánchez-Pernaute O, Marcos ME, Moreno-Rubio J, Aparicio C, Granado R, Ortega L, Egido J, Herrero-Beaumont G. Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. Arthritis Rheum 2008, 58:2723-2734. 10.1002/art.23765, 18759289.
25. Herrero-Beaumont G, Marcos ME, Sánchez-Pernaute O, Granados R, Ortega L, Montell E, Vergés J, Egido J, Largo R. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 2008, 154:843-851. 2439856, 18536737.
26. Boulocher CB, Viguier ER, Cararo Rda R, Fau DJ, Arnault F, Collard F, Maitre PA, Roualdes O, Duclos ME, Vignon EP, Roger TW. Radiographic assessment of the femorotibial joint of the CCLT rabbit experimental model of osteoarthritis. BMC Med Imaging 2010, 10:3. 10.1186/1471-2342-10-3, 2828401, 20089151.
27. Tiraloche G, Girard C, Chouinard L, Sampalis J, Moquin L, Ionescu M, Reiner A, Poole AR, Laverty S. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum 2005, 52:1118-1128. 10.1002/art.20951, 15818693.
28. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
29. Korb-Pap A, Stratis A, Mühlenberg K, Niederreiter B, Hayer S, Echtermeyer F, Stange R, Zwerina J, Pap T, Pavenstädt H, Schett G, Smolen JS, Redlich K. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann Rheum Dis 2012, 71:1004-1011. 10.1136/annrheumdis-2011-200386, 22258493.
30. Chen H, Shoumura S, Emura S, Isono H. Tibetan Medicated-Bath Therapy may Improve Adjuvant Arthritis in Rat. Evid Based Complement Alternat Med 2009, 6:211-217. 10.1093/ecam/nem083, 2686631, 18955278.
31. Verbruggen G, Wittoek R, Groeneboer S, Cruyssen BV, Goemaere S, Elewaut D. Osteochondral repair in synovial joints. Curr Opin Rheumatol 2007, 19:265-271. 10.1097/BOR.0b013e3280be58ff, 17414953.
32. Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Fransès RE, Mapp PI, Wilson D. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 2010, 49:1852-1861.
33. Pesesse L, Sanchez C, Henrotin Y. Osteochondral plate angiogenesis: a new treatment target in osteoarthritis. Joint Bone Spine 2011, 78:144-149. 10.1016/j.jbspin.2010.07.001, 20851653.
34. Brouwer E, Gouw AS, Posthumus MD, Van Leeuwen MA, Boerboom AL, Bijzet J, Bos R, Limburg PC, Kallenberg CG, Westra J. Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol 2009, 27:945-951.
35. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012, 8:390-398. 10.1038/nrrheum.2012.80, 22641138.
36. Yamamoto K, Shishido T, Masaoka T, Imakiire A. Morphological studies on the ageing and osteoarthritis of the articular cartilage in C57 black mice. J Orthop Surg (Hong Kong) 2005, 13:8-18.
37. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012, 11:763-776. 10.1038/nrd3794, 23023676.
38. Kuchroo VK, Awasthi A. Emerging new roles of Th17 cells. Eur J Immunol 2012, 42:2211-2214. 10.1002/eji.201242872, 22949318.
39. Lin J, Xiao L, Ouyang G, Shen Y, Huo R, Zhou Z, Sun Y, Zhu X, Zhang J, Shen B, Li N. Total glucosides of paeony inhibits Th1/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis. Cell Immunol 2012, 280:156-163. 10.1016/j.cellimm.2012.12.005, 23399842.
40. Yago T, Nanke Y, Ichikawa N, Kobashigawa T, Mogi M, Kamatani N, Kotake S. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem 2009, 108:947-955. 10.1002/jcb.22326, 19728295.
41. Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006, 54:1772-1777. 10.1002/art.21896, 16736519.
42. Ritchlin CT, Schwarz EM, O'Keefe RJ, Looney RJ. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis. J Musculoskelet Neuronal Interact 2004, 4:276-284.